After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...
This is to be expected, as only IgG can cross the placenta from the mother. Adults with subacute cutaneous lupus erythematosus will have IgG and IgM deposits on IF of skin lesions (Lee ...
Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback